| Cash Flow | 2025-06-30 |
|---|---|
| Stock-based compensation expense | 1,031 |
| Net loss | -13,671 |
| Non-cash operating lease expense | 11 |
| Provision for (reversal of) inventory reserve | 5 |
| Prepaid expense and other current assets | -169 |
| Other receivables | -484 |
| Operating lease liabilities | -12 |
| Inventory | 111 |
| Deferred revenue | -20 |
| Accrued and other current liabilities | -770 |
| Accounts receivable | -59 |
| Accounts payable | 91 |
| Foreign exchange (gain) loss | 623 |
| Depreciation expense | 17 |
| Warrant-related offering costs expensed | 448 |
| Change in fair value of derivative liability | -5,919 |
| Amortization of debt discount and imputed interest expense | 680 |
| Net cash used in operating activities | -6,293 |
| Repayment of notes payable | 1,560 |
| Proceeds from exercise of warrants | 3,734 |
| Proceeds from issuance of notes payable | 880 |
| Proceeds from issuance of warrants | 3,692 |
| Proceeds from issuance of common stock | 5,749 |
| Share issuance costs | 1,212 |
| Net cash provided by financing activities | 11,283 |
| Net increase in cash and cash equivalents | 4,990 |
HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)
HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)